Narinée Hovhannisyan

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria

N. Aide, C. Lasnon, E. Quak, 2014, Haematologica.

[18F]-Fludarabine for Hematological Malignancies

L. Barré, C. Bodet-Milin, F. Kraeber-Bodéré, 2019, Front. Med..

[18F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [18F]FDG in human xenograft models

S. Valable, M. Ibazizène, L. Barré, 2018, Theranostics.

One Health Probiotics as Biocontrol Agents: One Health Tomato Probiotics

A. Kushugulova, A. Pepoyan, Narinée Hovhannisyan, 2022, Plants.

Evaluation of the specificity of [18F]fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with [18F]FDG and impact of rituximab therapy

L. Barré, M. Leporrier, D. Patin, 2015, EJNMMI Research.

Evaluation of the specificity of ( 18 F)fludarabine PET/CT in a xenograft model of follicular lymphoma: comparison with ( 18 F)FDG and impact

L. Barré, M. Leporrier, D. Patin, 2015 .

18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients

M. Ibazizène, L. Barré, C. Bodet-Milin, 2018, The Journal of Nuclear Medicine.

[18F]Fludarabine-PET in a murine model of multiple myeloma

L. Barré, B. Sola, S. Guillouet, 2017, PloS one.